Metastatic Uveal Melanoma Recruiting Phase 2 / 3 Trials for Crizotinib (DB08865)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05987332IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal MelanomaTreatment